AACC appoints 2021 president, other leaders

By LabPulse.com staff writers

June 15, 2020 -- The American Association for Clinical Chemistry (AACC) has announced the appointment of its next president-elect as well as other personnel additions.

Dr. Stephen Master, PhD, will become president-elect and serve on the AACC's Board of Directors starting in August 2020 and president of the association in August 2021. Master heads the laboratory medicine department at the Children's Hospital of Philadelphia and is an associate professor of pathology and laboratory medicine at the Perelman School of Medicine at the University of Pennsylvania.

Other changes in the leadership include the appointment of the Mayo Clinic's Paul Jannetto, PhD, as AACC secretary from August 2020 to July 2023. Furthermore, Dr. Christopher McCudden, PhD, (Ottawa Hospital), Dr. Christine Schmotzer (Case Western Reserve University), and Dr. Gyorgy Abel (Lahey Health) will serve in three-year terms as members of the AACC Board of Directors starting in August.

AACC appoints Mark Golden as CEO
The American Association for Clinical Chemistry (AACC) has appointed Mark Golden as chief executive officer (CEO), effective August 17.
AACC launches research contest, will award deidentified blood samples
The American Association for Clinical Chemistry (AACC) is set to award large sets of deidentified blood samples to lab medicine teams who demonstrate...
AACC guidance urges caution on rapid POC coronavirus tests
When using rapid point-of-care (POC) tests for the novel coronavirus, healthcare institutions need to monitor the proficiency of operators and make sure...
AACC asks U.S. Senate to prioritize COVID-19 testing
The American Association for Clinical Chemistry (AACC) has sent a letter to U.S. Senate leadership with five recommendations to improve testing for the...

Copyright © 2020 LabPulse.com

Last Updated ls 6/15/2020 3:15:53 PM